dm+d
329325000
Articles
Specific medicine switches for solid dose and liquid formulations
13 September 2023
Certain medicines require additional monitoring and dose adjustments when switching between solid dose and liquid formulations. Safety considerations when using Vitamin D
7 September 2022
Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harmAlfacalcidol monitoring
5 July 2021
Refrigerated Storage
One-Alpha injection
Neon Healthcare LtdNeon Healthcare Ltd
One-Alpha injection
2 micrograms/mL injection
Contact Neon Healthcare Ltd in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
25 October 2021
London MI Service
One-Alpha oral drops
Neon Healthcare LtdNeon Healthcare Ltd
One-Alpha oral drops
2 micrograms/mL oral drops
Contact Neon Healthcare Ltd in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
25 October 2021
London MI Service
Lactation Safety Information
1-hydroxycholecalciferol
1-hydroxycholecalciferol
Used in full-term neonates from birth
Alfacalcidol is a synthetic analogue of vitamin D metabolised directly to calcitriol
Normally monitor infant’s calcium levels
11 September 2020